{"key":"op_790_ES","page":{"url":"https://fr.bookimed.com/clinics/country=spain/procedure=target-therapy-for-lung-cancer/","procedure":{"id":790,"slug":"target-therapy-for-lung-cancer","name":"Thérapie ciblée pour le cancer du poumon","name_forms":{"plural":{"status":"missing","reason":"not_collected"},"genitive":{"status":"missing","reason":"not_collected"}},"type":"therapy","grammar_number":{"status":"missing","reason":"not_collected"},"parent_id":"oncology","family_attribute":{"status":"missing","reason":"not_collected"}},"country":{"id":34,"iso":"ES","name":"Espagne"},"currency":"USD","data_date":"2026-10-27"},"pages":{"clinics_url":"https://fr.bookimed.com/clinics/country=spain/procedure=target-therapy-for-lung-cancer/","cost_url":"https://fr.bookimed.com/clinics/country=spain/procedure=target-therapy-for-lung-cancer/cost/","best_url":{"status":"missing","reason":"template not live"}},"price":{"from":4500,"to":13000,"avg":{"status":"missing","reason":"no_offers"},"us":{"from":90000,"to":150000},"uk":{"from":14000,"to":25000},"by_technique":[{"technique":"Oral EGFR tyrosine kinase inhibitor (osimertinib)","technique_id":"oral-egfr-tyrosine","price_from":5000,"currency":"USD","source":"estimate","date":"2026-11-17"},{"technique":"Other oral targeted inhibitors (ALK, ROS1, RET, MET, BRAF/MEK, KRAS G12C, HER2)","technique_id":"other-oral-targeted","price_from":4500,"currency":"USD","source":"estimate","date":"2026-11-17"},{"technique":"Antibody-based targeted regimens, such as EGFR-MET bispecific antibody or antibody-drug conjugates","technique_id":"antibody-based-targeted","price_from":8000,"currency":"USD","source":"estimate","date":"2026-11-17"}],"by_city":[{"city":"Barcelone","from":4500},{"city":"Pampelune","from":8400},{"city":"Alicante","from":3500},{"city":"Madrid","from":4800}],"per_unit":{"status":"missing","reason":"not_collected"},"factors":{"status":"missing","reason":"not_collected"},"tiers":{"status":"missing","reason":"no_offers"},"comparison":[{"country_iso":"UA","from":3500,"to":7000},{"country_iso":"FR","from":6500,"to":13000},{"country_iso":"GB","from":14000,"to":25000},{"country_iso":"US","from":90000,"to":150000},{"country_iso":"IL","from":9000,"to":16000},{"country_iso":"TR","from":5000,"to":5800},{"country_iso":"MX","from":6500,"to":12000},{"country_iso":"DE","from":3000,"to":27000},{"country_iso":"CA","from":9000,"to":20000},{"country_iso":"AE","from":9000,"to":14000},{"country_iso":"TH","from":9000,"to":13500},{"country_iso":"PL","from":4500,"to":8500},{"country_iso":"KR","from":2500,"to":15000},{"country_iso":"CZ","from":4500,"to":9000},{"country_iso":"AT","from":9000,"to":18000},{"country_iso":"IT","from":8200,"to":15900},{"country_iso":"CN","from":1600,"to":13000},{"country_iso":"AU","from":3800,"to":7500},{"country_iso":"IN","from":1000,"to":5500},{"country_iso":"MY","from":1800,"to":5400},{"country_iso":"VN","from":5000,"to":9500},{"country_iso":"BR","from":4500,"to":7000}],"base_country":"US","base_is_fallback":false},"savings":{"pct":95,"variant":">=15%"},"package":{"included":{"status":"missing","reason":"no_offers"},"excluded":{"status":"missing","reason":"no_offers"},"extra_charges":{"status":"missing","reason":"not_collected"}},"clinics":{"count":5,"items":[{"id":78,"name":"Centro Médico Teknon","city":"Barcelona","rating":4.7,"reviews_count":498,"accreditations":["Joint Commission International","European Foundation for Quality Management","THE IMTJ MEDICAL TRAVEL AWARD WINNER IN 2019","Patient choice in Neurology","Patient choice in Neurosurgery","Patient choice for Epilepsy treatment","World's Best Hospitals 2021 by Newsweek"],"rank":1,"has_procedure":true,"why_ranked":{"status":"missing","reason":"not_collected"},"bookimed_stats":{"status":"missing","reason":"not_published"},"procedure_description":{"status":"missing","reason":"not_collected"},"offers":{"status":"missing","reason":"no_offers"}},{"id":6225,"name":"Hospital Ruber Internacional","city":"Madrid","rating":5,"reviews_count":3,"accreditations":["Joint Commission International","International Organization for Standardization"],"rank":2,"has_procedure":true,"why_ranked":{"status":"missing","reason":"not_collected"},"bookimed_stats":{"status":"missing","reason":"not_published"},"procedure_description":{"status":"missing","reason":"not_collected"},"offers":{"status":"missing","reason":"no_offers"}},{"id":272,"name":"SJD Barcelona Children’s Hospital","city":"Barcelona","rating":4.7,"reviews_count":44,"accreditations":["Bookimed Award: Best pediatric hospital","World's Best Specialized Hospitals 2022 by Newsweek"],"rank":3,"has_procedure":true,"why_ranked":"On-site NGS and methylome analysis identify genetic targets to guide therapy. First in Spain certified for methylome profiling. Multidisciplinary tumor board selects treatment.","bookimed_stats":{"status":"missing","reason":"not_published"},"procedure_description":{"status":"missing","reason":"not_collected"},"offers":{"status":"missing","reason":"no_offers"}},{"id":339,"name":"Clinica Universidad de Navarra (Navarra Hospital)","city":"Pamplona","rating":4.7,"reviews_count":7,"accreditations":["Joint Commission International","European Society for Medical Oncology","World's Best Hospitals 2020 by Newsweek","World's Best Hospitals 2021 by Newsweek","World's Best Smart Hospitals 2021 by Newsweek","World's Best Hospitals 2022 by Newsweek","World's Best Smart Hospitals 2023 by Newsweek"],"rank":4,"has_procedure":true,"why_ranked":{"status":"missing","reason":"not_collected"},"bookimed_stats":{"status":"missing","reason":"not_published"},"procedure_description":{"status":"missing","reason":"not_collected"},"offers":{"status":"missing","reason":"no_offers"}},{"id":953,"name":"GenesisCare Clinics","city":"Madrid","rating":{"status":"missing","reason":"not_collected"},"reviews_count":{"status":"missing","reason":"not_collected"},"accreditations":{"status":"missing","reason":"not_collected"},"rank":5,"has_procedure":true,"why_ranked":{"status":"missing","reason":"not_collected"},"bookimed_stats":{"status":"missing","reason":"not_published"},"procedure_description":{"status":"missing","reason":"not_collected"},"offers":{"status":"missing","reason":"no_offers"}}]},"doctors":{"count":1,"languages":{"status":"missing","reason":"not_collected"}},"cities":[{"id":98,"slug":"barcelona","name":"Barcelone","clinics_count":1,"price_from":4500,"profile":{"city_type":"Mediterranean coastal city in Spain","access":["Barcelona Airport (BCN), 15 km southwest of city center"],"sources":["https://en.wikipedia.org/wiki/Barcelona","https://en.wikipedia.org/wiki/Barcelona–El_Prat_Airport"],"checked_at":"2026-11-03","status":"ok"}},{"id":366,"slug":"pamplona","name":"Pampelune","clinics_count":{"status":"missing","reason":"not_collected"},"price_from":8400,"profile":{"status":"missing","reason":"not_collected"}},{"id":441,"slug":"alicante","name":"Alicante","clinics_count":{"status":"missing","reason":"not_collected"},"price_from":3500,"profile":{"city_type":"Mediterranean port city in Spain","access":["Alicante Airport (ALC), 9 km from the city"],"sources":["https://en.wikipedia.org/wiki/Alicante","https://en.wikipedia.org/wiki/Alicante%E2%80%93Elche_Airport"],"checked_at":"2026-11-03","status":"ok"}},{"id":346,"slug":"madrid","name":"Madrid","clinics_count":{"status":"missing","reason":"not_collected"},"price_from":4800,"profile":{"city_type":"Capital and largest city of Spain","access":["Madrid Barajas Airport (MAD), 13 km from Puerta del Sol"],"sources":["https://en.wikipedia.org/wiki/Madrid","https://en.wikipedia.org/wiki/Madrid–Barajas_Airport"],"checked_at":"2026-11-03","status":"ok"}}],"offers":{"active":{"status":"missing","reason":"no_offers"},"active_with_related":{"status":"missing","reason":"no_offers"},"hospital_nights_median":{"status":"missing","reason":"no_offers"},"days_in_country_median":{"status":"missing","reason":"no_offers"},"top_offers":{"status":"missing","reason":"no_offers"},"packages":{"status":"missing","reason":"no_offers"},"related_packages":{"status":"missing","reason":"no_offers"},"other_packages":{"status":"missing","reason":"no_offers"}},"medical":{"indications":["Advanced or metastatic NSCLC with EGFR exon 19 deletion","Advanced or metastatic NSCLC with EGFR L858R mutation","Adjuvant therapy after resection of EGFR-mutated NSCLC","Unresectable stage III EGFR-mutated NSCLC after chemoradiotherapy"],"contraindications":["Severe hypersensitivity to osimertinib or its components.","Current interstitial lung disease or pneumonitis.","Congenital long QT syndrome or uncorrectable electrolyte disturbances.","Clinically significant cardiomyopathy or reduced ventricular function.","Strong CYP3A4 inducers (rifampin, carbamazepine, phenytoin, St John's wort).","Pregnancy or planned conception (not recommended)."],"operation_hours":{"min":0.5,"max":3,"unit":"hours","qualifier":"Initial clinic visit for counseling and start; daily tablet takes minutes and therapy continues until progression."},"anesthesia":["none"],"sessions_or_stages":{"sessions":{"min":4,"max":8,"unit":"visits","qualifier":"Planned oncology reviews in the first 6 months from treatment start."},"stages":[{"code":"baseline_start","label":"Baseline assessment, counseling and start of daily oral therapy","after":{"min":0,"max":0,"unit":"days","qualifier":"Counted from treatment start."}},{"code":"early_tolerability_review","label":"Tolerability and laboratory review","after":{"min":14,"max":28,"unit":"days","qualifier":"After the first dose."}},{"code":"first_response_assessment","label":"First response imaging and clinic review","after":{"min":42,"max":84,"unit":"days","qualifier":"After the first dose; timing varies by clinic."}},{"code":"ongoing_scheduled_reviews","label":"Ongoing reviews with periodic imaging every 2 to 3 months","after":{"min":84,"max":180,"unit":"days","qualifier":"After the first dose; later intervals individualized."}}],"qualifier":"Daily oral osimertinib after biomarker confirmation, continued until progression or intolerance. Counts cover first 6 months only."},"hospital_nights":{"value":{"min":0,"max":0,"unit":"nights","qualifier":"Oral therapy taken at home; no hospital stay in an uncomplicated course. Infusion-based regimens are outside this profile."},"source":"parsed_details"},"treatment_conditions":["outpatient"],"rehabilitation_days":{"min":0,"max":7,"unit":"days","qualifier":"Oral therapy without procedure; time to settle into daily routine, affected by rash, diarrhea, fatigue and disease burden."},"fly_home_after_days":{"min":0,"max":14,"unit":"days","qualifier":"No procedure; travel is possible after baseline workup, once stable with enough medication. Tolerability review at about 2–4 weeks."},"back_to_work_days":{"min":0,"max":7,"unit":"days","qualifier":"No procedure or stay; many patients with good performance status work within a week, adjusted for side effects."},"exercise_resume_weeks":{"min":0,"max":2,"unit":"weeks","qualifier":"Light activity from day 1; strenuous exercise gradually over 1 to 2 weeks if tolerability and breathing allow."},"final_result_months":{"min":1,"max":3,"unit":"months","qualifier":"Time to first radiologic response assessment, about 6 to 12 weeks. Not a cure endpoint; therapy continues."},"result_longevity":"Disease control typically lasts months to a few years until resistance develops; median first-line progression-free survival was roughly 1.5 years. Benefit lasts only during therapy; not a cure.","main_risks":["Diarrhea, dry skin, rash, paronychia, mouth sores; usually manageable.","Interstitial lung disease: rare but serious; stop drug, urgent evaluation.","QT prolongation; rarely reduced heart function.","Low blood counts and liver enzyme changes found on monitoring.","Eye symptoms and rare severe skin reactions.","Drug interactions, especially with CYP3A4 inducers."],"complication_rate_pct":{"min":1,"max":5,"unit":"percent","qualifier":"Approximate rate of interstitial lung disease or pneumonitis on osimertinib; milder effects like rash and diarrhea are far more common."},"revision_rate_pct":{"status":"missing","reason":"not_collected"},"success":{"metric":"Objective response rate (tumor shrinkage on imaging)","value":80,"horizon":"First response imaging, about 6 to 12 weeks after first dose","source":{"status":"missing","reason":"not_collected"},"evidence_status":"limited"},"scars":"None; no incisions.","pain":"Taking the oral tablet is painless. Treatment-related discomfort, such as mouth sores, nail-fold tenderness, rash or headache, can occur and is managed symptomatically.","preparation":["Confirm NSCLC and EGFR mutation by tissue or liquid biopsy","Baseline staging, usually CT with brain imaging, per the oncologist.","Baseline blood counts, liver and kidney tests, electrolytes","ECG and cardiac assessment as indicated","Review all medicines and supplements for CYP3A4 and QT interactions.","Counseling on side effects, dosing, skin and nail care","Contraception advice and when to contact the oncology team"],"recovery_timeline":[{"phase":"Treatment start (day 0)","description":"Baseline assessment and counseling, then daily oral osimertinib starts at home. No hospital stay; light activity continues from day 1.","restrictions":["Take the tablet daily as directed","Avoid interacting drugs and supplements unless cleared","Use contraception as advised"]},{"phase":"Days 1 to 28","description":"Mild diarrhea, dry skin, rash, nail changes, mouth sores and fatigue may appear; supportive care helps. Exercise resumes gradually.","restrictions":["Daily skin, nail and mouth care","Maintain hydration","Increase exercise gradually, guided by oncology team"]},{"phase":"Weeks 6 to 12","description":"First response imaging and clinic review; initial response is judged and monitoring continues.","restrictions":["Continue treatment unless the oncology team advises otherwise"]},{"phase":"Ongoing therapy (months 3 to 6 and beyond)","description":"Daily therapy with periodic reviews and imaging until progression or intolerance; repeat testing if disease progresses.","restrictions":["Continue regular monitoring as scheduled","Do not stop or change dose without oncology advice"]},{"phase":"At any time","description":"Seek urgent care for new cough, breathlessness, fever, chest pain, palpitations, severe diarrhea, severe rash, eye pain, or infection or bleeding signs.","restrictions":["Do not wait for the next review","Team may pause the drug during assessment"]}],"follow_up_visits":[{"purpose":"assessment","requirement":"routine","after":{"min":14,"max":28,"unit":"days","qualifier":"After the first dose; tolerability and laboratory review."}},{"purpose":"result_review","requirement":"routine","after":{"min":42,"max":84,"unit":"days","qualifier":"After the first dose; first response imaging and clinic review."}},{"purpose":"assessment","requirement":"routine","after":{"min":84,"max":180,"unit":"days","qualifier":"After the first dose; periodic imaging every 2 to 3 months, later intervals individualized."}}],"sources":{"status":"missing","reason":"not_collected"},"clinic_checks":{"status":"ok","items":[{"id":"C1","text":"Check that the doctor explains the risks of any biopsy needed for the tumor before it is done","scope":"treatment_type","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies","host":"cancer.gov","quote":"Your doctor will explain the risks of having a biopsy for your type of tumor.","tier":"tier1_medical","fetched_at":"2026-11-14","http_status":200}},{"id":"C2","text":"Check whether the doctor explains that cancer cells can become resistant to targeted therapy","scope":"treatment_type","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies","host":"cancer.gov","quote":"Cancer cells can become resistant to targeted therapy.","tier":"tier1_medical","fetched_at":"2026-11-14","http_status":200}},{"id":"C3","text":"Check the plan for regular visits, blood tests and scans, which show whether the treatment is working","scope":"treatment_type","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies","host":"cancer.gov","quote":"These regular visits and tests will help the doctor know whether the treatment is working.","tier":"tier1_medical","fetched_at":"2026-11-14","http_status":200}},{"id":"C4","text":"Check that the side effects of the specific targeted drug you would receive are explained before treatment starts","scope":"treatment_type","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies","host":"cancer.gov","quote":"The side effects that you may have depends on the type of targeted therapy you receive and how your body reacts to it.","tier":"tier1_medical","fetched_at":"2026-11-14","http_status":200}},{"id":"C5","text":"Check that your tumor has been tested for drug targets, which is needed most of the time","scope":"treatment_type","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies","host":"cancer.gov","quote":"But most of the time, your tumor will need to be tested to see if it contains targets for which there is a drug.","tier":"tier1_medical","fetched_at":"2026-11-14","http_status":200}}],"checked_at":"2026-11-14","next_check_at":"2027-11-14","version":1},"red_flags":{"status":"ok","items":[{"id":"F1","text":"Promise that the doctor can know for certain how you will feel during treatment","scope":"treatment_type","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies","host":"cancer.gov","quote":"Doctors and nurses cannot know for certain how you will feel during treatment.","tier":"tier1_medical","fetched_at":"2026-11-14","http_status":200}},{"id":"F2","text":"Ad or quote calling targeted therapy free of serious side effects","scope":"treatment_type","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies","host":"cancer.gov","quote":"But they have learned that targeted therapy can also cause serious side effects.","tier":"tier1_medical","fetched_at":"2026-11-14","http_status":200}},{"id":"F3","text":"Targeted therapy offered without any mention of testing the tumor for drug targets","scope":"treatment_type","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies","host":"cancer.gov","quote":"But most of the time, your tumor will need to be tested to see if it contains targets for which there is a drug.","tier":"tier1_medical","fetched_at":"2026-11-14","http_status":200}}],"checked_at":"2026-11-14","next_check_at":"2027-11-14","version":1},"warning_signs":{"status":"ok","items":[{"id":"W1","text":"Trouble breathing","urgency":"emergency","general":false,"source":{"url":"https://www.cancer.gov/types/lung/patient/non-small-cell-lung-treatment-pdq","host":"cancer.gov","quote":"chest discomfort or pain; a cough that doesn't go away or gets worse over time; trouble breathing; wheezing; blood in sputum (mucus coughed up from the lungs)","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},{"id":"W2","text":"Worsening cough","urgency":"contact_clinic","general":false,"source":{"url":"https://www.cancer.gov/types/lung/patient/non-small-cell-lung-treatment-pdq","host":"cancer.gov","quote":"chest discomfort or pain; a cough that doesn't go away or gets worse over time; trouble breathing; wheezing; blood in sputum (mucus coughed up from the lungs)","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},{"id":"W3","text":"Blood in sputum","urgency":"contact_clinic","general":false,"source":{"url":"https://www.cancer.gov/types/lung/patient/non-small-cell-lung-treatment-pdq","host":"cancer.gov","quote":"chest discomfort or pain; a cough that doesn't go away or gets worse over time; trouble breathing; wheezing; blood in sputum (mucus coughed up from the lungs)","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}}],"checked_at":"2026-11-14","next_check_at":"2027-11-14","version":1},"take_home":{"status":"ok","items":[{"id":"T1","text":"Home doctor needs the clinic's follow-up recommendations in a written discharge summary","document":"discharge summary","source":{"url":"https://sbuhb.nhs.wales/about-us/individual-patient-commissioning/ipc-folder/advice-on-accessing-treatment-abroad","host":"sbuhb.nhs.wales","quote":"When you have treatment abroad, you must ask the treatment provider for their follow-up recommendations documented within a written discharge summary in English.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"T2","text":"Ask for copies of all prescriptions before you leave","document":"prescription copies","source":{"url":"https://travelhealthpro.org.uk/news/699/travelling-abroad-for-treatment","host":"travelhealthpro.org.uk","quote":"Remember to ask for copies of all your treatment records, including prescriptions, scans and x-rays before you leave.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"T3","text":"Home doctor needs the dates for required blood tests and follow-up appointments","document":"written aftercare plan","source":{"url":"https://sbuhb.nhs.wales/about-us/individual-patient-commissioning/ipc-folder/advice-on-accessing-treatment-abroad","host":"sbuhb.nhs.wales","quote":"This should include any medication and doses, as well as any dates that blood tests and follow-up appointments must be carried out.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}}],"checked_at":"2026-11-14","next_check_at":"2027-11-14","version":1},"preop_tests":{"status":"ok","items":[{"id":"T1","name":"EGFR mutation test","aliases":["EGFR mutation test","EGFR mutation","EGFR","tissue biopsy","liquid biopsy","EGFR and other biomarker test"],"kind":"lab","origin":[{"field":"preparation","text":"Confirm NSCLC and EGFR mutation by tissue or liquid biopsy"},{"field":"initial_assessment_documents","text":"EGFR and other biomarker test report (NGS)"}],"what_it_checks":{"text":"Checks for lung tumor gene changes treatable with targeted therapy","source":{"url":"https://medlineplus.gov/lab-tests/lung-cancer-genetic-tests/","host":"medlineplus.gov","quote":"So, lung cancer genetic tests can help your provider find out whether your cancer has a gene change that may be treated with a targeted therapy.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T2","name":"Next-generation sequencing (NGS) test","aliases":["Next-generation sequencing (NGS) test","NGS","next-generation sequencing"],"kind":"lab","origin":[{"field":"initial_assessment_documents","text":"EGFR and other biomarker test report (NGS)"}],"what_it_checks":{"text":"Checks several tumor gene changes in one test","source":{"url":"https://medlineplus.gov/lab-tests/lung-cancer-genetic-tests/","host":"medlineplus.gov","quote":"Because there are many types of gene changes that can be involved in NSCLC, your provider may check for several of these changes in one lung cancer genetic test.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T3","name":"Complete blood count","aliases":["Complete blood count","CBC","full blood count","blood counts"],"kind":"lab","origin":[{"field":"preparation","text":"Baseline blood counts, liver and kidney tests, electrolytes"}],"what_it_checks":{"text":"Monitors blood cell counts that treatment may affect","source":{"url":"https://medlineplus.gov/lab-tests/complete-blood-count-cbc/","host":"medlineplus.gov","quote":"It is also used to monitor a condition or treatment that may affect your blood cell counts such as infections, anemia, immune system disorders, and blood cancers.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":{"text":"You may need to fast for several hours if other tests are ordered","source":{"url":"https://medlineplus.gov/lab-tests/complete-blood-count-cbc/","host":"medlineplus.gov","quote":"But if your provider ordered other tests on your blood sample, you may need to fast (not eat or drink) for several hours before the test.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}}},{"id":"T4","name":"Liver function test","aliases":["Liver function test","liver tests","liver function","liver and kidney tests","liver and kidney function","LFT","Kidney function test","kidney tests","kidney function","RFT"],"kind":"lab","origin":[{"field":"preparation","text":"Baseline blood counts, liver and kidney tests, electrolytes"},{"field":"initial_assessment_documents","text":"Recent blood tests with liver and kidney function"}],"what_it_checks":{"text":"Checks how well the liver works and whether it is damaged","source":{"url":"https://medlineplus.gov/lab-tests/liver-function-tests/","host":"medlineplus.gov","quote":"Some of these tests can show how well your liver is working and others can show whether your liver may be damaged by liver disease or injury.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":{"text":"You will probably need to fast for 10–12 hours before the test","source":{"url":"https://medlineplus.gov/lab-tests/liver-function-tests/","host":"medlineplus.gov","quote":"You will probably need to fast (not eat or drink) for 10-12 hours before the test.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}}},{"id":"T5","name":"Electrolytes test","aliases":["Electrolytes test","electrolytes"],"kind":"lab","origin":[{"field":"preparation","text":"Baseline blood counts, liver and kidney tests, electrolytes"}],"what_it_checks":{"text":"Checks for electrolyte, fluid, or pH imbalances","source":{"url":"https://medlineplus.gov/lab-tests/electrolyte-panel/","host":"medlineplus.gov","quote":"An electrolyte panel is used to check for electrolyte, fluid, or pH imbalances.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T6","name":"Blood tests","aliases":["Blood tests","recent blood tests"],"kind":"lab","origin":[{"field":"initial_assessment_documents","text":"Recent blood tests with liver and kidney function"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T7","name":"CT scan","aliases":["CT scan","CT","Chest CT"],"kind":"imaging","origin":[{"field":"preparation","text":"Baseline staging, usually CT with brain imaging, per the oncologist."},{"field":"initial_assessment_documents","text":"Chest CT or PET-CT report and images"}],"what_it_checks":{"text":"Makes detailed pictures of the chest and other body areas","source":{"url":"https://www.cancer.gov/types/lung/patient/small-cell-lung-treatment-pdq","host":"cancer.gov","quote":"CT scan (CAT scan) uses a computer linked to an x-ray machine to make a series of detailed pictures of areas inside the body, such as the brain, chest, and abdomen.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T8","name":"PET-CT scan","aliases":["PET-CT scan","PET-CT"],"kind":"imaging","origin":[{"field":"initial_assessment_documents","text":"Chest CT or PET-CT report and images"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":{"text":"Remove jewellery and other objects containing metal before the scan","source":{"url":"https://www.nhs.uk/tests-and-treatments/pet-scan/","host":"nhs.uk","quote":"You'll need to remove any jewellery and other objects containing metal.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}}},{"id":"T9","name":"Brain imaging","aliases":["Brain imaging"],"kind":"imaging","origin":[{"field":"preparation","text":"Baseline staging, usually CT with brain imaging, per the oncologist."}],"what_it_checks":{"text":"Makes detailed pictures of the brain and other body areas","source":{"url":"https://www.cancer.gov/types/lung/patient/non-small-cell-lung-treatment-pdq","host":"cancer.gov","quote":"CT scan (CAT scan) of the brain, chest, and abdomen uses a computer linked to an x-ray machine to make a series of detailed pictures of areas inside the body.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T10","name":"Brain MRI","aliases":["Brain MRI","MRI"],"kind":"imaging","origin":[{"field":"initial_assessment_documents","text":"Brain MRI report"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null}],"checked_at":"2026-11-17","next_check_at":"2027-11-17","version":1},"prep_in_advance":{"status":"ok","items":[{"id":"P1","action":"Ask your treatment team whether your tumor needs biomarker testing before targeted therapy","why":"Testing shows whether the tumor has a target that a drug can attack","who_decides":"","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies","host":"cancer.gov","quote":"But most of the time, your tumor will need to be tested to see if it contains targets for which there is a drug.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}}],"checked_at":"2026-11-17","next_check_at":"2027-11-17","version":1},"visit_and_day":{"status":"ok","has_procedure_day":false,"items":[{"id":"V1","text":"Testing your cancer for targets that could help choose your treatment is called biomarker testing","anesthesia":"any","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies","host":"cancer.gov","quote":"Testing your cancer for targets that could help choose your treatment is called biomarker testing.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},{"id":"V2","text":"A biopsy is a procedure in which your doctor removes a piece of the tumor for testing","anesthesia":"any","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies","host":"cancer.gov","quote":"A biopsy is a procedure in which your doctor removes a piece of the tumor for testing.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},{"id":"V3","text":"Your doctor will explain the risks of having a biopsy for your type of tumor","anesthesia":"any","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies","host":"cancer.gov","quote":"Your doctor will explain the risks of having a biopsy for your type of tumor.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},{"id":"V4","text":"Targeted therapy uses drugs or other substances to identify and attack specific cancer cells","anesthesia":"any","source":{"url":"https://www.cancer.gov/types/lung/patient/non-small-cell-lung-treatment-pdq","host":"cancer.gov","quote":"Targeted therapy uses drugs or other substances to identify and attack specific cancer cells.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}}],"checked_at":"2026-11-17","next_check_at":"2027-11-17","version":1},"if_something_changes":{"status":"missing","reason":"no_official_source","checked_at":"2026-11-17","next_check_at":"2027-02-15"}},"parsed_details":{"procedure_type":"therapy","fields":{"anesthesia":["none"],"back_to_work_days":{"min":0,"max":7,"unit":"days","qualifier":"No procedure or stay; many patients with good performance status work within a week, adjusted for side effects."},"complication_rate_pct":{"min":1,"max":5,"unit":"percent","qualifier":"Approximate rate of interstitial lung disease or pneumonitis on osimertinib; milder effects like rash and diarrhea are far more common."},"contraindications":["Severe hypersensitivity to osimertinib or its components.","Current interstitial lung disease or pneumonitis.","Congenital long QT syndrome or uncorrectable electrolyte disturbances.","Clinically significant cardiomyopathy or reduced ventricular function.","Strong CYP3A4 inducers (rifampin, carbamazepine, phenytoin, St John's wort).","Pregnancy or planned conception (not recommended)."],"days_in_clinic":{"min":0,"max":0,"unit":"nights","qualifier":"Oral therapy taken at home; no hospital stay in an uncomplicated course. Infusion-based regimens are outside this profile."},"diagnostic_duration_minutes":null,"diagnostic_preparation":null,"diagnostic_referral_needed":null,"diagnostic_result_time_hours":null,"exercise_resume_weeks":{"min":0,"max":2,"unit":"weeks","qualifier":"Light activity from day 1; strenuous exercise gradually over 1 to 2 weeks if tolerability and breathing allow."},"final_result_months":{"min":1,"max":3,"unit":"months","qualifier":"Time to first radiologic response assessment, about 6 to 12 weeks. Not a cure endpoint; therapy continues."},"fly_home_after_days":{"min":0,"max":14,"unit":"days","qualifier":"No procedure; travel is possible after baseline workup, once stable with enough medication. Tolerability review at about 2–4 weeks."},"follow_up_visits":[{"purpose":"assessment","requirement":"routine","after":{"min":14,"max":28,"unit":"days","qualifier":"After the first dose; tolerability and laboratory review."}},{"purpose":"result_review","requirement":"routine","after":{"min":42,"max":84,"unit":"days","qualifier":"After the first dose; first response imaging and clinic review."}},{"purpose":"assessment","requirement":"routine","after":{"min":84,"max":180,"unit":"days","qualifier":"After the first dose; periodic imaging every 2 to 3 months, later intervals individualized."}}],"indications":["Advanced or metastatic NSCLC with EGFR exon 19 deletion","Advanced or metastatic NSCLC with EGFR L858R mutation","Adjuvant therapy after resection of EGFR-mutated NSCLC","Unresectable stage III EGFR-mutated NSCLC after chemoradiotherapy"],"main_risks":["Diarrhea, dry skin, rash, paronychia, mouth sores; usually manageable.","Interstitial lung disease: rare but serious; stop drug, urgent evaluation.","QT prolongation; rarely reduced heart function.","Low blood counts and liver enzyme changes found on monitoring.","Eye symptoms and rare severe skin reactions.","Drug interactions, especially with CYP3A4 inducers."],"pain":"Taking the oral tablet is painless. Treatment-related discomfort, such as mouth sores, nail-fold tenderness, rash or headache, can occur and is managed symptomatically.","preparation":["Confirm NSCLC and EGFR mutation by tissue or liquid biopsy","Baseline staging, usually CT with brain imaging, per the oncologist.","Baseline blood counts, liver and kidney tests, electrolytes","ECG and cardiac assessment as indicated","Review all medicines and supplements for CYP3A4 and QT interactions.","Counseling on side effects, dosing, skin and nail care","Contraception advice and when to contact the oncology team"],"recovery_timeline":[{"phase":"Treatment start (day 0)","description":"Baseline assessment and counseling, then daily oral osimertinib starts at home. No hospital stay; light activity continues from day 1.","restrictions":["Take the tablet daily as directed","Avoid interacting drugs and supplements unless cleared","Use contraception as advised"]},{"phase":"Days 1 to 28","description":"Mild diarrhea, dry skin, rash, nail changes, mouth sores and fatigue may appear; supportive care helps. Exercise resumes gradually.","restrictions":["Daily skin, nail and mouth care","Maintain hydration","Increase exercise gradually, guided by oncology team"]},{"phase":"Weeks 6 to 12","description":"First response imaging and clinic review; initial response is judged and monitoring continues.","restrictions":["Continue treatment unless the oncology team advises otherwise"]},{"phase":"Ongoing therapy (months 3 to 6 and beyond)","description":"Daily therapy with periodic reviews and imaging until progression or intolerance; repeat testing if disease progresses.","restrictions":["Continue regular monitoring as scheduled","Do not stop or change dose without oncology advice"]},{"phase":"At any time","description":"Seek urgent care for new cough, breathlessness, fever, chest pain, palpitations, severe diarrhea, severe rash, eye pain, or infection or bleeding signs.","restrictions":["Do not wait for the next review","Team may pause the drug during assessment"]}],"rehabilitation_days":{"min":0,"max":7,"unit":"days","qualifier":"Oral therapy without procedure; time to settle into daily routine, affected by rash, diarrhea, fatigue and disease burden."},"result_longevity":"Disease control typically lasts months to a few years until resistance develops; median first-line progression-free survival was roughly 1.5 years. Benefit lasts only during therapy; not a cure.","revision_rate_pct":null,"scars":"None; no incisions.","sessions_or_stages":{"sessions":{"min":4,"max":8,"unit":"visits","qualifier":"Planned oncology reviews in the first 6 months from treatment start."},"stages":[{"code":"baseline_start","label":"Baseline assessment, counseling and start of daily oral therapy","after":{"min":0,"max":0,"unit":"days","qualifier":"Counted from treatment start."}},{"code":"early_tolerability_review","label":"Tolerability and laboratory review","after":{"min":14,"max":28,"unit":"days","qualifier":"After the first dose."}},{"code":"first_response_assessment","label":"First response imaging and clinic review","after":{"min":42,"max":84,"unit":"days","qualifier":"After the first dose; timing varies by clinic."}},{"code":"ongoing_scheduled_reviews","label":"Ongoing reviews with periodic imaging every 2 to 3 months","after":{"min":84,"max":180,"unit":"days","qualifier":"After the first dose; later intervals individualized."}}],"qualifier":"Daily oral osimertinib after biomarker confirmation, continued until progression or intolerance. Counts cover first 6 months only."},"success":{"metric":"Objective response rate (tumor shrinkage on imaging)","value":80,"unit":"percent","horizon":"First response imaging, about 6 to 12 weeks after first dose","population":"Adults with advanced EGFR exon 19 or L858R NSCLC on first-line osimertinib","evidence_status":"limited"},"techniques":[{"name":"Oral EGFR tyrosine kinase inhibitor (osimertinib)","suits_whom":"Adults with EGFR-mutated advanced NSCLC.","recovery":"Taken at home daily; no procedural recovery, with side-effect management and monitoring as directed."},{"name":"Other oral targeted inhibitors (ALK, ROS1, RET, MET, BRAF/MEK, KRAS G12C, HER2)","suits_whom":"Patients with the matching actionable alteration; the choice follows biomarker results and approvals.","recovery":"Taken at home as continuous therapy; monitoring and side effects are agent-specific."},{"name":"Antibody-based targeted regimens, such as EGFR-MET bispecific antibody or antibody-drug conjugates","suits_whom":"Selected patients with specific alterations or after progression on oral inhibitors; availability varies.","recovery":"Given by intravenous infusion in a treatment unit; schedules and observation are product-specific."}],"treatment_conditions":["outpatient"],"treatment_duration_hours":{"min":0.5,"max":3,"unit":"hours","qualifier":"Initial clinic visit for counseling and start; daily tablet takes minutes and therapy continues until progression."},"initial_assessment_documents":["Lung biopsy pathology report","EGFR and other biomarker test report (NGS)","Chest CT or PET-CT report and images","Brain MRI report","Recent blood tests with liver and kidney function","Previous cancer treatment summary (if available)"],"travel_trips":{"min":1,"max":3,"one_trip_possible":true,"qualifier":"Daily oral therapy; one 1-2 week trip covers workup and start; imaging and reviews may need return trips."},"clinic_checks":{"status":"ok","items":[{"id":"C1","text":"Check that the doctor explains the risks of any biopsy needed for the tumor before it is done","scope":"treatment_type","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies","host":"cancer.gov","quote":"Your doctor will explain the risks of having a biopsy for your type of tumor.","tier":"tier1_medical","fetched_at":"2026-11-14","http_status":200}},{"id":"C2","text":"Check whether the doctor explains that cancer cells can become resistant to targeted therapy","scope":"treatment_type","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies","host":"cancer.gov","quote":"Cancer cells can become resistant to targeted therapy.","tier":"tier1_medical","fetched_at":"2026-11-14","http_status":200}},{"id":"C3","text":"Check the plan for regular visits, blood tests and scans, which show whether the treatment is working","scope":"treatment_type","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies","host":"cancer.gov","quote":"These regular visits and tests will help the doctor know whether the treatment is working.","tier":"tier1_medical","fetched_at":"2026-11-14","http_status":200}},{"id":"C4","text":"Check that the side effects of the specific targeted drug you would receive are explained before treatment starts","scope":"treatment_type","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies","host":"cancer.gov","quote":"The side effects that you may have depends on the type of targeted therapy you receive and how your body reacts to it.","tier":"tier1_medical","fetched_at":"2026-11-14","http_status":200}},{"id":"C5","text":"Check that your tumor has been tested for drug targets, which is needed most of the time","scope":"treatment_type","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies","host":"cancer.gov","quote":"But most of the time, your tumor will need to be tested to see if it contains targets for which there is a drug.","tier":"tier1_medical","fetched_at":"2026-11-14","http_status":200}}],"checked_at":"2026-11-14","next_check_at":"2027-11-14","version":1},"red_flags":{"status":"ok","items":[{"id":"F1","text":"Promise that the doctor can know for certain how you will feel during treatment","scope":"treatment_type","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies","host":"cancer.gov","quote":"Doctors and nurses cannot know for certain how you will feel during treatment.","tier":"tier1_medical","fetched_at":"2026-11-14","http_status":200}},{"id":"F2","text":"Ad or quote calling targeted therapy free of serious side effects","scope":"treatment_type","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies","host":"cancer.gov","quote":"But they have learned that targeted therapy can also cause serious side effects.","tier":"tier1_medical","fetched_at":"2026-11-14","http_status":200}},{"id":"F3","text":"Targeted therapy offered without any mention of testing the tumor for drug targets","scope":"treatment_type","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies","host":"cancer.gov","quote":"But most of the time, your tumor will need to be tested to see if it contains targets for which there is a drug.","tier":"tier1_medical","fetched_at":"2026-11-14","http_status":200}}],"checked_at":"2026-11-14","next_check_at":"2027-11-14","version":1},"warning_signs":{"status":"ok","items":[{"id":"W1","text":"Trouble breathing","urgency":"emergency","general":false,"source":{"url":"https://www.cancer.gov/types/lung/patient/non-small-cell-lung-treatment-pdq","host":"cancer.gov","quote":"chest discomfort or pain; a cough that doesn't go away or gets worse over time; trouble breathing; wheezing; blood in sputum (mucus coughed up from the lungs)","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},{"id":"W2","text":"Worsening cough","urgency":"contact_clinic","general":false,"source":{"url":"https://www.cancer.gov/types/lung/patient/non-small-cell-lung-treatment-pdq","host":"cancer.gov","quote":"chest discomfort or pain; a cough that doesn't go away or gets worse over time; trouble breathing; wheezing; blood in sputum (mucus coughed up from the lungs)","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},{"id":"W3","text":"Blood in sputum","urgency":"contact_clinic","general":false,"source":{"url":"https://www.cancer.gov/types/lung/patient/non-small-cell-lung-treatment-pdq","host":"cancer.gov","quote":"chest discomfort or pain; a cough that doesn't go away or gets worse over time; trouble breathing; wheezing; blood in sputum (mucus coughed up from the lungs)","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}}],"checked_at":"2026-11-14","next_check_at":"2027-11-14","version":1},"take_home":{"status":"ok","items":[{"id":"T1","text":"Home doctor needs the clinic's follow-up recommendations in a written discharge summary","document":"discharge summary","source":{"url":"https://sbuhb.nhs.wales/about-us/individual-patient-commissioning/ipc-folder/advice-on-accessing-treatment-abroad","host":"sbuhb.nhs.wales","quote":"When you have treatment abroad, you must ask the treatment provider for their follow-up recommendations documented within a written discharge summary in English.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"T2","text":"Ask for copies of all prescriptions before you leave","document":"prescription copies","source":{"url":"https://travelhealthpro.org.uk/news/699/travelling-abroad-for-treatment","host":"travelhealthpro.org.uk","quote":"Remember to ask for copies of all your treatment records, including prescriptions, scans and x-rays before you leave.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"T3","text":"Home doctor needs the dates for required blood tests and follow-up appointments","document":"written aftercare plan","source":{"url":"https://sbuhb.nhs.wales/about-us/individual-patient-commissioning/ipc-folder/advice-on-accessing-treatment-abroad","host":"sbuhb.nhs.wales","quote":"This should include any medication and doses, as well as any dates that blood tests and follow-up appointments must be carried out.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}}],"checked_at":"2026-11-14","next_check_at":"2027-11-14","version":1},"alternatives":{"status":"ok","items":[{"id":"A1","text":"Your lung cancer can be removed with surgery","name":"Lung cancer surgery","source":{"url":"https://www.nhs.uk/conditions/lung-cancer/treatment/","host":"nhs.uk","quote":"You may have surgery to remove cancer from your lung.","tier":"tier1_medical","fetched_at":"2026-11-14","http_status":200},"operation_id":374}],"checked_at":"2026-11-14","next_check_at":"2027-11-14","version":1},"technique_details":{"status":"ok","items":[{"id":"oral-egfr-tyrosine","name":"Oral EGFR tyrosine kinase inhibitor (osimertinib)","how_it_works":{"status":"missing","reason":"no_official_source"},"recovery_daily":{"status":"missing","reason":"no_official_source"}},{"id":"other-oral-targeted","name":"Other oral targeted inhibitors (ALK, ROS1, RET, MET, BRAF/MEK, KRAS G12C, HER2)","how_it_works":{"status":"missing","reason":"no_official_source"},"recovery_daily":{"status":"missing","reason":"no_official_source"}},{"id":"antibody-based-targeted","name":"Antibody-based targeted regimens, such as EGFR-MET bispecific antibody or antibody-drug conjugates","how_it_works":{"status":"missing","reason":"no_official_source"},"recovery_daily":{"status":"missing","reason":"no_official_source"}}],"checked_at":"2026-11-14","next_check_at":"2027-11-14","version":1},"preop_tests":{"status":"ok","items":[{"id":"T1","name":"EGFR mutation test","aliases":["EGFR mutation test","EGFR mutation","EGFR","tissue biopsy","liquid biopsy","EGFR and other biomarker test"],"kind":"lab","origin":[{"field":"preparation","text":"Confirm NSCLC and EGFR mutation by tissue or liquid biopsy"},{"field":"initial_assessment_documents","text":"EGFR and other biomarker test report (NGS)"}],"what_it_checks":{"text":"Checks for lung tumor gene changes treatable with targeted therapy","source":{"url":"https://medlineplus.gov/lab-tests/lung-cancer-genetic-tests/","host":"medlineplus.gov","quote":"So, lung cancer genetic tests can help your provider find out whether your cancer has a gene change that may be treated with a targeted therapy.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T2","name":"Next-generation sequencing (NGS) test","aliases":["Next-generation sequencing (NGS) test","NGS","next-generation sequencing"],"kind":"lab","origin":[{"field":"initial_assessment_documents","text":"EGFR and other biomarker test report (NGS)"}],"what_it_checks":{"text":"Checks several tumor gene changes in one test","source":{"url":"https://medlineplus.gov/lab-tests/lung-cancer-genetic-tests/","host":"medlineplus.gov","quote":"Because there are many types of gene changes that can be involved in NSCLC, your provider may check for several of these changes in one lung cancer genetic test.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T3","name":"Complete blood count","aliases":["Complete blood count","CBC","full blood count","blood counts"],"kind":"lab","origin":[{"field":"preparation","text":"Baseline blood counts, liver and kidney tests, electrolytes"}],"what_it_checks":{"text":"Monitors blood cell counts that treatment may affect","source":{"url":"https://medlineplus.gov/lab-tests/complete-blood-count-cbc/","host":"medlineplus.gov","quote":"It is also used to monitor a condition or treatment that may affect your blood cell counts such as infections, anemia, immune system disorders, and blood cancers.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":{"text":"You may need to fast for several hours if other tests are ordered","source":{"url":"https://medlineplus.gov/lab-tests/complete-blood-count-cbc/","host":"medlineplus.gov","quote":"But if your provider ordered other tests on your blood sample, you may need to fast (not eat or drink) for several hours before the test.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}}},{"id":"T4","name":"Liver function test","aliases":["Liver function test","liver tests","liver function","liver and kidney tests","liver and kidney function","LFT","Kidney function test","kidney tests","kidney function","RFT"],"kind":"lab","origin":[{"field":"preparation","text":"Baseline blood counts, liver and kidney tests, electrolytes"},{"field":"initial_assessment_documents","text":"Recent blood tests with liver and kidney function"}],"what_it_checks":{"text":"Checks how well the liver works and whether it is damaged","source":{"url":"https://medlineplus.gov/lab-tests/liver-function-tests/","host":"medlineplus.gov","quote":"Some of these tests can show how well your liver is working and others can show whether your liver may be damaged by liver disease or injury.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":{"text":"You will probably need to fast for 10–12 hours before the test","source":{"url":"https://medlineplus.gov/lab-tests/liver-function-tests/","host":"medlineplus.gov","quote":"You will probably need to fast (not eat or drink) for 10-12 hours before the test.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}}},{"id":"T5","name":"Electrolytes test","aliases":["Electrolytes test","electrolytes"],"kind":"lab","origin":[{"field":"preparation","text":"Baseline blood counts, liver and kidney tests, electrolytes"}],"what_it_checks":{"text":"Checks for electrolyte, fluid, or pH imbalances","source":{"url":"https://medlineplus.gov/lab-tests/electrolyte-panel/","host":"medlineplus.gov","quote":"An electrolyte panel is used to check for electrolyte, fluid, or pH imbalances.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T6","name":"Blood tests","aliases":["Blood tests","recent blood tests"],"kind":"lab","origin":[{"field":"initial_assessment_documents","text":"Recent blood tests with liver and kidney function"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T7","name":"CT scan","aliases":["CT scan","CT","Chest CT"],"kind":"imaging","origin":[{"field":"preparation","text":"Baseline staging, usually CT with brain imaging, per the oncologist."},{"field":"initial_assessment_documents","text":"Chest CT or PET-CT report and images"}],"what_it_checks":{"text":"Makes detailed pictures of the chest and other body areas","source":{"url":"https://www.cancer.gov/types/lung/patient/small-cell-lung-treatment-pdq","host":"cancer.gov","quote":"CT scan (CAT scan) uses a computer linked to an x-ray machine to make a series of detailed pictures of areas inside the body, such as the brain, chest, and abdomen.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T8","name":"PET-CT scan","aliases":["PET-CT scan","PET-CT"],"kind":"imaging","origin":[{"field":"initial_assessment_documents","text":"Chest CT or PET-CT report and images"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":{"text":"Remove jewellery and other objects containing metal before the scan","source":{"url":"https://www.nhs.uk/tests-and-treatments/pet-scan/","host":"nhs.uk","quote":"You'll need to remove any jewellery and other objects containing metal.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}}},{"id":"T9","name":"Brain imaging","aliases":["Brain imaging"],"kind":"imaging","origin":[{"field":"preparation","text":"Baseline staging, usually CT with brain imaging, per the oncologist."}],"what_it_checks":{"text":"Makes detailed pictures of the brain and other body areas","source":{"url":"https://www.cancer.gov/types/lung/patient/non-small-cell-lung-treatment-pdq","host":"cancer.gov","quote":"CT scan (CAT scan) of the brain, chest, and abdomen uses a computer linked to an x-ray machine to make a series of detailed pictures of areas inside the body.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T10","name":"Brain MRI","aliases":["Brain MRI","MRI"],"kind":"imaging","origin":[{"field":"initial_assessment_documents","text":"Brain MRI report"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null}],"checked_at":"2026-11-17","next_check_at":"2027-11-17","version":1},"prep_in_advance":{"status":"ok","items":[{"id":"P1","action":"Ask your treatment team whether your tumor needs biomarker testing before targeted therapy","why":"Testing shows whether the tumor has a target that a drug can attack","who_decides":"","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies","host":"cancer.gov","quote":"But most of the time, your tumor will need to be tested to see if it contains targets for which there is a drug.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}}],"checked_at":"2026-11-17","next_check_at":"2027-11-17","version":1},"visit_and_day":{"status":"ok","has_procedure_day":false,"items":[{"id":"V1","text":"Testing your cancer for targets that could help choose your treatment is called biomarker testing","anesthesia":"any","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies","host":"cancer.gov","quote":"Testing your cancer for targets that could help choose your treatment is called biomarker testing.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},{"id":"V2","text":"A biopsy is a procedure in which your doctor removes a piece of the tumor for testing","anesthesia":"any","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies","host":"cancer.gov","quote":"A biopsy is a procedure in which your doctor removes a piece of the tumor for testing.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},{"id":"V3","text":"Your doctor will explain the risks of having a biopsy for your type of tumor","anesthesia":"any","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies","host":"cancer.gov","quote":"Your doctor will explain the risks of having a biopsy for your type of tumor.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},{"id":"V4","text":"Targeted therapy uses drugs or other substances to identify and attack specific cancer cells","anesthesia":"any","source":{"url":"https://www.cancer.gov/types/lung/patient/non-small-cell-lung-treatment-pdq","host":"cancer.gov","quote":"Targeted therapy uses drugs or other substances to identify and attack specific cancer cells.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}}],"checked_at":"2026-11-17","next_check_at":"2027-11-17","version":1},"if_something_changes":{"status":"missing","reason":"no_official_source","checked_at":"2026-11-17","next_check_at":"2027-02-15"}}},"techniques":[{"id":"oral-egfr-tyrosine","name":"Oral EGFR tyrosine kinase inhibitor (osimertinib)","how_it_works":{"status":"missing","reason":"no_official_source"},"recovery_daily":{"status":"missing","reason":"no_official_source"},"suits_whom":"Adults with EGFR-mutated advanced NSCLC.","price_from":5000,"recovery":"Taken at home daily; no procedural recovery, with side-effect management and monitoring as directed."},{"id":"other-oral-targeted","name":"Other oral targeted inhibitors (ALK, ROS1, RET, MET, BRAF/MEK, KRAS G12C, HER2)","how_it_works":{"status":"missing","reason":"no_official_source"},"recovery_daily":{"status":"missing","reason":"no_official_source"},"suits_whom":"Patients with the matching actionable alteration; the choice follows biomarker results and approvals.","price_from":4500,"recovery":"Taken at home as continuous therapy; monitoring and side effects are agent-specific."},{"id":"antibody-based-targeted","name":"Antibody-based targeted regimens, such as EGFR-MET bispecific antibody or antibody-drug conjugates","how_it_works":{"status":"missing","reason":"no_official_source"},"recovery_daily":{"status":"missing","reason":"no_official_source"},"suits_whom":"Selected patients with specific alterations or after progression on oral inhibitors; availability varies.","price_from":8000,"recovery":"Given by intravenous infusion in a treatment unit; schedules and observation are product-specific."}],"alternatives":{"status":"ok","items":[{"id":"A1","text":"Your lung cancer can be removed with surgery","name":"Lung cancer surgery","source":{"url":"https://www.nhs.uk/conditions/lung-cancer/treatment/","host":"nhs.uk","quote":"You may have surgery to remove cancer from your lung.","tier":"tier1_medical","fetched_at":"2026-11-14","http_status":200},"operation_id":374}],"checked_at":"2026-11-14","next_check_at":"2027-11-14","version":1},"diagnostic":{"status":"not_applicable"},"country":{"why":{"status":"missing","reason":"no_official_source","checked_at":"2026-11-11","next_check_at":"2027-02-09"},"travel":{"status":"ok","items":[{"id":"V1","item":"passport_validity","audience":"uk","volatile":true,"text":"The passport must have an expiry date at least 3 months after you plan to leave the Schengen area","source":{"url":"https://www.gov.uk/foreign-travel-advice/spain/entry-requirements","host":"gov.uk","quote":"have an ‘expiry date’ at least 3 months after the day you plan to leave the Schengen area (the expiry date does not need to be within 10 years of the date of issue)","tier":"official_travel","fetched_at":"2026-11-11","http_status":200}},{"id":"V2","item":"medicines","audience":"all","volatile":false,"text":"Carry prescription medication in its original packaging, along with your doctor's prescription","source":{"url":"https://travel.state.gov/content/travel/en/international-travel/International-Travel-Country-Information-Pages/Spain.html","host":"travel.state.gov","quote":"Always carry your prescription medication in original packaging, along with your doctor’s prescription.","tier":"official_travel","fetched_at":"2026-11-11","http_status":403}},{"id":"V3","item":"prescriptions","audience":"us","volatile":false,"text":"Medications that require a prescription in the United States also require a local doctor's prescription in Spain","source":{"url":"https://travel.state.gov/content/travel/en/international-travel/International-Travel-Country-Information-Pages/Spain.html","host":"travel.state.gov","quote":"Medications requiring prescriptions in the United States also require a local doctor’s prescription in Spain.","tier":"official_travel","fetched_at":"2026-11-11","http_status":403}},{"id":"V4","item":"ghic","audience":"uk","volatile":false,"text":"A GHIC or EHIC is needed to get medically necessary state healthcare in Spain","source":{"url":"https://www.gov.uk/foreign-travel-advice/spain/health","host":"gov.uk","quote":"To get medically necessary state healthcare in Spain, you need a Global Health Insurance Card ( GHIC ) or a European Health Insurance Card ( EHIC ).","tier":"official_travel","fetched_at":"2026-11-11","http_status":200}},{"id":"V5","item":"hospital_payment","audience":"all","volatile":false,"text":"Private hospitals usually require payment or proof of insurance or funds before admitting a patient","source":{"url":"https://travel.state.gov/content/travel/en/international-travel/International-Travel-Country-Information-Pages/Spain.html","host":"travel.state.gov","quote":"Private hospitals usually require payment or proof insurance or funds before admitting a patient.","tier":"official_travel","fetched_at":"2026-11-11","http_status":403}},{"id":"V6","item":"emergency_number","audience":"all","volatile":false,"text":"Dial 112 and ask for an ambulance","source":{"url":"https://www.gov.uk/foreign-travel-advice/spain/health","host":"gov.uk","quote":"Dial 112 and ask for an ambulance.","tier":"official_travel","fetched_at":"2026-11-11","http_status":200}}],"checked_at":"2026-11-11","next_check_at":"2026-12-11","version":1},"other_countries_with_page":["china","egypt","germany","india","republic-of-korea","switzerland","thailand","turkey","ukraine"]},"often_combined_with":{"status":"missing","reason":"not_collected"},"reviews":{"avg_rating":4.7,"count":552,"scope":"clinic","rating_scale":5,"pros":{"status":"missing","reason":"not_collected"},"cons":{"status":"missing","reason":"not_collected"}},"current":{"seo_text":"<p>Target therapy for lung cancer in Spain typically costs from _op_790_price_from_ to _op_790_price_to_. Total expenses depend on the specific molecular profile, brand of medication, and the duration of the treatment course. In the United States, patients pay around _price_compare_US_average_ on average for similar therapies. Spain offers significant savings of approximately _price_percent_discount_%. Protocols generally include genetic testing and oncological consultations.</p>\n\n<ul>\n<li><strong>Diagnostic profiling:</strong> Biomarker and genetic testing often add 10-15% to the initial diagnostic budget.</li>\n<li><strong>Treatment cycles:</strong> Private clinics generally price medications and administration starting from approximately $5,000 per dose.</li>\n<li><strong>Main medical hubs:</strong> Premier oncology centers are primarily located in Madrid, Barcelona, and Pamplona.</li>\n<li><strong>Hospital tiering:</strong> Pricing for international patients varies between top-ranked private hospitals and specialized oncology networks.</li>\n</ul>\n\n<p><strong>Bookimed Expert Insight:</strong> Choosing JCI-accredited centers like Clinica Universidad de Navarra or Hospital Ruber Internacional ensures access to advanced technologies. These institutions often use AI and robotic systems to enhance treatment precision. While per-dose costs are lower than in the US, international patients should budget for long-term oral therapy. Many Spanish centers, such as SJD Barcelona, maintain exceptional survival rates for complex oncological cases. Investing in a high-tier clinic often provides inclusive access to multidisciplinary teams and luxury private suites.</p>","faq":[{"q":"Is biomarker testing mandatory before starting targeted therapy?","a":"<p>Biomarker testing is a clinical necessity before starting targeted therapy for lung cancer in Spain. While not a universal legal requirement for all patients, health authorities like the Spanish Agency of Medicines and Medical Devices (AEMPS) mandate these tests to approve and prescribe specific targeted drugs.</p> <ul> <li><strong>Clinical standard:</strong> Testing identifies genomic variants like EGFR, ALK, and ROS1 to guide treatment selection.</li> <li><strong>Treatment efficacy:</strong> Targeted oral therapies remain ineffective if the specific genetic mutation is not present.</li> <li><strong>Toxicology prevention:</strong> Selecting biomarkers first prevents severe toxicities from less effective, aggressive alternative treatments.</li> <li><strong>Spanish regulation:</strong> AEMPS guidelines require molecular profiling to authorize personalized medicine protocols in Spain.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> Spanish oncology centers often integrate biomarker testing with advanced diagnostics like 3-Tesla MRI. Facilities such as Clinica Universidad de Navarra maintain European Society for Medical Oncology accreditation. This ensures testing protocols align with the latest international precision medicine standards for faster results. This integration is crucial because patients who wait for genetic results before starting therapy often see better long-term stability.</p> <p><strong>Patient Consensus:</strong> Patients emphasize that genetic testing is a non-negotiable step that provides a clear roadmap for personalized care. Many recommend explicitly asking your medical team for these results before consenting to standard chemotherapy.</p>"},{"q":"What are the available targeted therapies for lung cancer in Spain?","a":"<p>Targeted lung cancer therapies in Spain utilize precision medicine to treat specific genetic mutations like EGFR, ALK, and ROS1. Leading oncology centers provide advanced inhibitors including Osimertinib and Selpercatinib, alongside innovative clinical trials for KRAS G12C and MYC mutations at JCI-accredited facilities.</p> <ul> <li><strong>Biomarker testing:</strong> Essential molecular diagnostics identify driver mutations like EGFR, ALK, and ROS1 prior to treatment.</li> <li><strong>Current medications:</strong> Targeted drugs include Osimertinib for EGFR and Selpercatinib for RET fusion-positive lung cancer.</li> <li><strong>Innovative access:</strong> Clinical trials provide early access to KRAS G12C inhibitors and novel cancer vaccines.</li> <li><strong>Specialized facilities:</strong> Major centers like Clinica Universidad de Navarra maintain European Society for Medical Oncology accreditation.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> Spain presents a unique research-heavy landscape where patients access tomorrow's drugs today. Centers like Hospital Ruber Internacional and Navarra prioritize early-phase trials for MYC inhibitors like OMO-103. This clinical trial focus often bypasses standard reimbursement delays seen in the public sector.</p> <p><strong>Patient Consensus:</strong> Accuracy in initial genetic testing is the most critical step for success. Patients emphasize discussing drug resistance early and pursuing clinical trial options for the newest inhibitors.</p>"},{"q":"Can I participate in clinical trials for targeted therapy in Spain?","a":"<p>You can participate in clinical trials for targeted therapy in Spain, which is a global leader in oncological research. Patients access cutting-edge biomarker-driven treatments and Phase 1 trials, including innovative lung cancer vaccines like BNT116, at JCI-accredited centers in Madrid, Barcelona, and Pamplona.</p> <ul> <li><strong>Biomarker testing:</strong> Mandatory screenings for ALK, KRAS, and EGFR mutations determine trial eligibility.</li> <li><strong>Expert centers:</strong> Clinica Universidad de Navarra is a leading JCI-accredited research hub.</li> <li><strong>Advanced therapies:</strong> Programs include triple-drug combinations and molecular-guided experimental protocols.</li> <li><strong>Trial resources:</strong> Search the EU Clinical Trials Register filtered by specific mutation types.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> Spain is one of only 7 global sites for the BNT116 lung cancer vaccine trial. Clinics like Clinica Universidad de Navarra offer high-level integration between research and care. This allows patients with rare mutations to access Phase 1 experimental treatments long before they reach the general market.</p> <p><strong>Patient Consensus:</strong> Patients emphasize that early biomarker testing is vital. Many suggest looking beyond standard care into Phase 1 trials if you have specific resistance patterns or rare lung cancer mutations.</p>"},{"q":"How does the National Health System (SNS) in Spain cover targeted therapies?","a":"<p>Spains National Health System (SNS) provides universal coverage for targeted therapies that are approved by the Ministry of Health. Patients access these treatments through public hospitals, where tax-funded care is free at delivery, though regional variations in availability and pharmaceutical co-payments may apply.</p> <ul> <li><strong>Biomarker testing:</strong> Genetic testing for EGFR, ALK, or ROS1 is mandatory for treatment eligibility.</li> <li><strong>Approval process:</strong> Therapies must pass strict Ministry of Health reimbursement reviews before full funding.</li> <li><strong>Access pathway:</strong> Patients can request exceptional authorization for non-listed medicines via hospital therapeutic committees.</li> <li><strong>Co-payment rules:</strong> Seniors pay 10% for pharmacy prescriptions, while most inpatient oncology drugs remain free.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> While public coverage is universal, private centers like Clinica Universidad de Navarra or Hospital Ruber Internacional offer faster access to trials. Data shows these JCI-accredited facilities often implement digital imaging and molecular labs for specialized lung cancer care earlier than public regional centers.</p> <p><strong>Patient Consensus:</strong> Navigating health bureaucracy is easier when contacting patient associations for support. Most confirm that once a drug is on the national list, costs become negligible for low-income families.</p>"},{"q":"What are the best hospitals or medical centers in Spain for lung cancer?","a":"<p>Spain hosts world-class oncology centers like Clinica Universidad de Navarra and Hospital Ruber Internacional, specializing in targeted lung cancer therapy. These Joint Commission International-accredited facilities offer advanced treatments including CyberKnife, immunotherapy, and molecular medicine within highly integrated research-led networks.</p> <ul> <li><strong>Hospital Ruber Internacional:</strong> Madrid center utilizing CyberKnife, Gamma Knife, and Da Vinci Xi technology.</li> <li><strong>Clinica Universidad de Navarra:</strong> European Society for Medical Oncology-accredited hospital leads in multidisciplinary research.</li> <li><strong>GenesisCare Clinics:</strong> Specializes in advanced radiotherapy techniques like tomotherapy and precise brachytherapy.</li> <li><strong>Diagnostic efficiency:</strong> Spanish oncologists prioritize rapid diagnostic protocols for urgent, life-threatening cases.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> Spain’s oncology strength lies in research integration rather than single-center dominance. Clinics like Navarra maintain Joint Commission International status while serving 140,000 patients annually. This high volume ensures surgeons maintain precision in robotic and molecular treatments. Patients should target Madrid for the concentrated expertise found at Forbes-ranked institutions.</p> <p><strong>Patient Consensus:</strong> Patients value the speed of Spanish diagnostics for suspected lung cancer. Many recommend starting private treatment for immediate access, then transitioning to public care for long-term medication coverage.</p>"}],"h2":[{"text":"Quel est le Coût pour votre Thérapie ciblée pour le cancer du poumon en Espagne ?","kind":"content"},{"text":"Vos avantages et garanties avec Bookimed","kind":"content"},{"text":"Votre coordinateur médical personnel","kind":"content"},{"text":"Découvrez les Meilleures Cliniques pour Votre Thérapie ciblée pour le cancer du poumon en Espagne : 5 Options Vérifiées et Prix","kind":"content"},{"text":"Aperçu de thérapie ciblée pour le cancer du poumon en Espagne","kind":"content"},{"text":"Obtenez une évaluation médicale pour Thérapie ciblée pour le cancer du poumon en Espagne : Choisissez le meilleur spécialiste dans le domaine","kind":"content"},{"text":"Histoires vidéo des patients de Bookimed","kind":"content"},{"text":"Avis sur Bookimed : Découvrez l'Expérience des Patients","kind":"content"},{"text":"Partager ce contenu","kind":"content"},{"text":"FAQ de thérapie ciblée pour le cancer du poumon en Espagne","kind":"content"},{"text":"Obtenez une consultation gratuite","kind":"content"}]},"placeholders":{"price_from":"{{price_from}}","clinics_count":"{{clinics_count}}","cities_count":"{{cities_count}}","savings_pct":"{{savings_pct}}","data_date":"{{data_date}}"},"legal":{"restricted_markets":{"status":"missing","reason":"not_collected"}},"conflicts":[]}